Cargando…
Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction
Placental insufficiency is associated with fetal hypoglycemia, hypoxemia, and elevated plasma norepinephrine (NE) that become increasingly pronounced throughout the third trimester and contribute to intrauterine growth restriction (IUGR). This study evaluated the effect of fetal adrenal demedullatio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303851/ https://www.ncbi.nlm.nih.gov/pubmed/25584967 http://dx.doi.org/10.3390/nu7010500 |
_version_ | 1782353985483571200 |
---|---|
author | Davis, Melissa A. Macko, Antoni R. Steyn, Leah V. Anderson, Miranda J. Limesand, Sean W. |
author_facet | Davis, Melissa A. Macko, Antoni R. Steyn, Leah V. Anderson, Miranda J. Limesand, Sean W. |
author_sort | Davis, Melissa A. |
collection | PubMed |
description | Placental insufficiency is associated with fetal hypoglycemia, hypoxemia, and elevated plasma norepinephrine (NE) that become increasingly pronounced throughout the third trimester and contribute to intrauterine growth restriction (IUGR). This study evaluated the effect of fetal adrenal demedullation (AD) on growth and pancreatic endocrine cell mass. Placental insufficiency-induced IUGR was created by exposing pregnant ewes to elevated ambient temperatures during mid-gestation. Treatment groups consisted of control and IUGR fetuses with either surgical sham or AD at 98 days gestational age (dGA; term = 147 dGA), a time-point that precedes IUGR. Samples were collected at 134 dGA. IUGR-sham fetuses were hypoxemic, hypoglycemic, and hypoinsulinemic, and values were similar in IUGR-AD fetuses. Plasma NE concentrations were ~5-fold greater in IUGR-sham compared to control-sham, control-AD, and IUGR-AD fetuses. IUGR-sham and IUGR-AD fetuses weighed less than controls. Compared to IUGR-sham fetuses, IUGR-AD fetuses weighed more and asymmetrical organ growth was absent. Pancreatic β-cell mass and α-cell mass were lower in both IUGR-sham and IUGR-AD fetuses compared to controls, however, pancreatic endocrine cell mass relative to fetal mass was lower in IUGR-AD fetuses. These findings indicate that NE, independently of hypoxemia, hypoglycemia and hypoinsulinemia, influence growth and asymmetry of growth but not pancreatic endocrine cell mass in IUGR fetuses. |
format | Online Article Text |
id | pubmed-4303851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-43038512015-02-02 Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction Davis, Melissa A. Macko, Antoni R. Steyn, Leah V. Anderson, Miranda J. Limesand, Sean W. Nutrients Article Placental insufficiency is associated with fetal hypoglycemia, hypoxemia, and elevated plasma norepinephrine (NE) that become increasingly pronounced throughout the third trimester and contribute to intrauterine growth restriction (IUGR). This study evaluated the effect of fetal adrenal demedullation (AD) on growth and pancreatic endocrine cell mass. Placental insufficiency-induced IUGR was created by exposing pregnant ewes to elevated ambient temperatures during mid-gestation. Treatment groups consisted of control and IUGR fetuses with either surgical sham or AD at 98 days gestational age (dGA; term = 147 dGA), a time-point that precedes IUGR. Samples were collected at 134 dGA. IUGR-sham fetuses were hypoxemic, hypoglycemic, and hypoinsulinemic, and values were similar in IUGR-AD fetuses. Plasma NE concentrations were ~5-fold greater in IUGR-sham compared to control-sham, control-AD, and IUGR-AD fetuses. IUGR-sham and IUGR-AD fetuses weighed less than controls. Compared to IUGR-sham fetuses, IUGR-AD fetuses weighed more and asymmetrical organ growth was absent. Pancreatic β-cell mass and α-cell mass were lower in both IUGR-sham and IUGR-AD fetuses compared to controls, however, pancreatic endocrine cell mass relative to fetal mass was lower in IUGR-AD fetuses. These findings indicate that NE, independently of hypoxemia, hypoglycemia and hypoinsulinemia, influence growth and asymmetry of growth but not pancreatic endocrine cell mass in IUGR fetuses. MDPI 2015-01-09 /pmc/articles/PMC4303851/ /pubmed/25584967 http://dx.doi.org/10.3390/nu7010500 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Davis, Melissa A. Macko, Antoni R. Steyn, Leah V. Anderson, Miranda J. Limesand, Sean W. Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction |
title | Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction |
title_full | Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction |
title_fullStr | Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction |
title_full_unstemmed | Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction |
title_short | Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction |
title_sort | fetal adrenal demedullation lowers circulating norepinephrine and attenuates growth restriction but not reduction of endocrine cell mass in an ovine model of intrauterine growth restriction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303851/ https://www.ncbi.nlm.nih.gov/pubmed/25584967 http://dx.doi.org/10.3390/nu7010500 |
work_keys_str_mv | AT davismelissaa fetaladrenaldemedullationlowerscirculatingnorepinephrineandattenuatesgrowthrestrictionbutnotreductionofendocrinecellmassinanovinemodelofintrauterinegrowthrestriction AT mackoantonir fetaladrenaldemedullationlowerscirculatingnorepinephrineandattenuatesgrowthrestrictionbutnotreductionofendocrinecellmassinanovinemodelofintrauterinegrowthrestriction AT steynleahv fetaladrenaldemedullationlowerscirculatingnorepinephrineandattenuatesgrowthrestrictionbutnotreductionofendocrinecellmassinanovinemodelofintrauterinegrowthrestriction AT andersonmirandaj fetaladrenaldemedullationlowerscirculatingnorepinephrineandattenuatesgrowthrestrictionbutnotreductionofendocrinecellmassinanovinemodelofintrauterinegrowthrestriction AT limesandseanw fetaladrenaldemedullationlowerscirculatingnorepinephrineandattenuatesgrowthrestrictionbutnotreductionofendocrinecellmassinanovinemodelofintrauterinegrowthrestriction |